Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Alasdair Smith currently holds 50,000 shares of Medicus Pharma Ltd. (MDCX), valued at approximately $0. This represents their equity stake as Chief Operating Officer.
Based on SEC Form 4 filings, Andrew Alasdair Smith has been a net neutral trader of MDCX stock. They have purchased $0 and sold $0 worth of shares.
Andrew Alasdair Smith's most recent insider trade was on Mar 30, 2026, when they sold 50,000 shares at $0.00 per share.
Andrew Alasdair Smith serves as Chief Operating Officer at Medicus Pharma Ltd. (MDCX). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Andrew Alasdair Smith holds the position of Chief Operating Officer at Medicus Pharma Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Andrew Alasdair Smith has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Andrew Alasdair Smith was on Mar 30, 2026, when they purchased $0 worth of MDCX shares. This transaction involved 50,000 shares at N/A per share.
Andrew Alasdair Smith currently owns 50,000 shares of Medicus Pharma Ltd. (MDCX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Alasdair Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Alasdair Smith has 1 Form 4 filings on record as an insider at Medicus Pharma Ltd..
Set alerts for Andrew Alasdair Smith and 40,000+ other insiders.